Evidence map›Paper›PMID 35980472›Full record

SynthesisParasitology research2022

Molecular assays for determining sulphadoxine-pyrimethamine drug resistance in India: a systematic review.

Shradha Bhullar, Neelima Mishra

Abstract readSystematic Review
PubMed Publisher
In one paragraph

Synthesis in Parasitology research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Shradha BhullarParasite-Host Biology Group, ICMR-National Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110077, India.
Neelima MishraParasite-Host Biology Group, ICMR-National Institute of Malaria Research, Sector 8, Dwarka, New Delhi, 110077, India. neelima1.nimr@gmail.com.ORCID http://orcid.org/0000-0002-1736-368X

Funding

Department of Health Research, Government of India R.12013/23/2020-HR
6 · The paper itself

Abstract

A plethora of studies analyse the molecular markers of drug resistance and hence help in guiding the evidence-based malaria treatment policies in India. For reporting mutations, a number of techniques including DNA sequencing, restriction-fragment length polymorphism and mutation-specific polymerase chain reaction have been employed across numerous studies, including variations in the methodology used. However, there is no sufficient data from India comparing these methods as well as report the prevalence of polymorphisms in SP drug resistance molecular markers independently using such methods. Therefore, all data from Indian studies available for molecular marker studies of Plasmodium falciparum drug resistance to sulphadoxine-pyrimethamine was gathered, and a systematic review was performed. This systematic review identifies the molecular methods in use in India and compares each method for detecting sulphadoxine-pyrimethamine drug resistance marker. To delay the spread of drug-resistant parasite strains, a simplified and standardized molecular method is much needed which can be obtained by analysing the performance of each method in use and answering the necessity of newer methodological approaches.

Indexed as

AntimalarialsMalaria, FalciparumDrug CombinationsDrug ResistanceHumansIndiaPlasmodium falciparumPyrimethamineSulfadoxineAntimalarialsDrug Combinationsfanasil, pyrimethamine drug combinationPyrimethamineSulfadoxineDNA sequencingDrug resistanceMutation-specific polymerase chain reactionPlasmodium falciparumRestriction-fragment length polymorphismSulphadoxine-pyrimethamine

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.